0001593968-22-000890.txt : 20220429
0001593968-22-000890.hdr.sgml : 20220429
20220429161001
ACCESSION NUMBER: 0001593968-22-000890
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220427
FILED AS OF DATE: 20220429
DATE AS OF CHANGE: 20220429
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCLAUGHLIN KEVIN F
CENTRAL INDEX KEY: 0001214938
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35280
FILM NUMBER: 22875390
MAIL ADDRESS:
STREET 1: C/O ACCELERON PHARMA INC.
STREET 2: 128 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vericel Corp
CENTRAL INDEX KEY: 0000887359
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943096597
STATE OF INCORPORATION: MI
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 7349305555
MAIL ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC
DATE OF NAME CHANGE: 19960428
4
1
primary_01.xml
PRIMARY DOCUMENT
X0306
4
2022-04-27
0000887359
Vericel Corp
VCEL
0001214938
MCLAUGHLIN KEVIN F
C/O VERICEL CORPORATION
64 SIDNEY STREET
CAMBRIDGE
MA
02139
true
false
false
false
Common Stock
2022-04-27
4
M
false
2600
A
6100
D
Restricted Stock Unit
2022-04-27
4
M
false
2600
0
D
Common Stock
2600
0
D
Stock Option (right to buy)
31.99
2022-04-27
4
A
false
6500
0
A
2032-04-27
Common Stock
6500
6500
D
Restricted Stock Unit
2022-04-27
4
A
false
2600
0
A
Common Stock
2600
2600
D
The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on April 28, 2021.
Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.
These RSUs vest 100% on the earlier of April 28, 2022 or the date of the first Annual Meeting of Stockholders following April 28, 2021. The first Annual Meeting of Stockholders occurred on April 27, 2022.
No expiration date for this type of award.
The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company.
These RSUs vest 100% on the earlier of April 27, 2023 or the date of the first Annual Meeting of Stockholders following April 27, 2022.
/s/ Sean Flynn, as Attorney-in-Fact for Kevin McLaughlin
2022-04-29